{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T21:08:57Z","timestamp":1780693737328,"version":"3.54.1"},"reference-count":25,"publisher":"Oncology Nursing Society (ONS)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ONF"],"published-print":{"date-parts":[[2016,7,1]]},"DOI":"10.1188\/16.onf.413-416","type":"journal-article","created":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T15:10:54Z","timestamp":1466176254000},"page":"413-416","source":"Crossref","is-referenced-by-count":2,"title":["Acute Aortic Dissection Following Treatment for Castration-Resistant \u2028Prostate Cancer"],"prefix":"10.1188","volume":"43","author":[{"given":"Tara","family":"Horrill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1302","published-online":{"date-parts":[[2016,7,1]]},"reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Albertsen, P.C. (2015). Observational studies and the natural history of screen-detected prostate cancer. Current Opinion in Urology, 25, 232\u2013237. doi:10.1097\/MOU.0000000000000157","DOI":"10.1097\/MOU.0000000000000157"},{"key":"2","unstructured":"American Cancer Society. (2016). Key statistics for prostate cancer. Retrieved from http:\/\/www.cancer.org\/cancer\/prostate\u2028cancer\/detailedguide\/prostate-cancer\u2028-key-statistics"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Argarwal, P.K., Sadetsky, N., Konety, B.R., Resnick, M.I., & Carroll, P.R. (2008). Treatment failure after primary and salvage therapy for prostate cancer. Cancer, 112, 307\u2013314. doi:10.1002\/cncr.23161","DOI":"10.1002\/cncr.23161"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Beer, T.M., Armstrong, A.J., Rathkopf, D.E., Loriot, C.N., Sternberg, C.S., Higano, P., . . . Tombal, B. (2014). Enzalutamide in metastatic prostate cancer before chemotherapy. New England Journal of Medicine, 371, 424\u2013433.","DOI":"10.1056\/NEJMoa1405095"},{"key":"5","unstructured":"Canadian Cancer Society. (2015). Canadian cancer statistics 2015. Retrieved from https:\/\/www.cancer.ca\/~\/media\/cancer\u2028.ca\/CW\/cancer%20information\/cancer%20101\/Canadian%20cancer%20statistics\/Canadian-Cancer-Statistics-2015-EN.pdf"},{"key":"6","doi-asserted-by":"crossref","unstructured":"de Bono, J., Logothetis, C.J., Molina, A., Fizazi, K., North, S., Chu, L., . . . Scher, H.I. (2011). Abiraterone and increased survival in metastatic prostate cancer. New England Journal of Medicine, 364, 1995\u20132005.","DOI":"10.1056\/NEJMoa1014618"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Erbel, R., Alfonso, F., Boileau, C., Dirsch, O., Eber, B., Haverich, A., . . . Zollikofer, C. (2001). Diagnosis and management of aortic dissection: Recommendations of the Task Force on Aortic Dissection, European Society of Cardiology. European Heart Journal, 22, 1642\u20131681.","DOI":"10.1053\/euhj.2001.2782"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Golledge, J., & Eagle, K.A. (2008). Acute aortic dissection. Lancet, 372, 55\u201366.","DOI":"10.1016\/S0140-6736(08)60994-0"},{"key":"9","unstructured":"Kellogg Parsons, J., & Partin, A.W. (2006). Clinical management of rising prostate-specific antigen after radical retropubic prostatectomy. In S.R. Kirby, A.W. Partin, M.R. Feneley, & J. Kellogg Parsons (Eds.), Prostate cancer: Principles and practice (pp. 747\u2013754). London, England: Taylor and Francis."},{"key":"10","doi-asserted-by":"crossref","unstructured":"Koutsopoulou, S., Papathanassoglou, E.D.E., Katapodi, M.C., & Patiraki, E.I. (2010). A critical review of the evidence for nurses as information providers to cancer patients. Journal of Clinical Nursing, 19, 749\u2013765. doi:10.1111\/j.1365-2702.2009.02954.x","DOI":"10.1111\/j.1365-2702.2009.02954.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Mohler, J., Bahanson, R.R., Boston, B., Busby, J.E., D\u2019Amico, A., Eastham, J.A., . . . Walsh, P.E. (2010). NCCN Clinical Practice Guidelines in Oncology: Prostate cancer. Journal of the National Comprehensive Cancer Network, 8, 162\u2013200.","DOI":"10.6004\/jnccn.2010.0012"},{"key":"12","unstructured":"Nienaber, C.A., & Clough, R.E. (2015). Management of acute aortic dissection. Lancet, 385, 800\u2013811. doi:10.1016\/S0140-6736 (14)61005-9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Papadopoulos, D.P., Sanidas, E.A., Viniou, N.A., Gennimata, V., Chantziara, V., Barbetseas, I., & Makris, T.K. (2015). Cardiovascular hypertensive emergencies. Current Hypertension Reports, 17, 5. doi:10.1007\/s11906-014-0515-z","DOI":"10.1007\/s11906-014-0515-z"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Pape, L.A., Awais, M., Woznicki, E.M., Suzuki, T., Trimarchi, S., Evangelista, A., . . . O\u2019Gara, P. (2015). Presentation, diagnosis and outcomes of acute aortic dissection: 17 year trends from the International Registry of Acute Aortic Dissection. Journal of the American College of Cardiology, 66, 350\u2013358. doi:10.1016\/j.jacc.2015.05.029","DOI":"10.1016\/j.jacc.2015.05.029"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Pound, C.R., Partin, A.W., Eisenberger, M.A., Chan, D.W., Pearson, J.D., & Walsh, P.C. (1999). Natural history of progression after PSA elevation following radical prostatectomy. JAMA, 281, 1591\u20131597. doi:10.1001\/jama.281.17.1591","DOI":"10.1001\/jama.281.17.1591"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Punnen, S., & Cooperberg, M.R. (2013). The epidemiology of high-risk prostate cancer. Current Opinion in Urology, 23, 331\u2013336. doi:10.1097\/MOU.0b013e328361d48e","DOI":"10.1097\/MOU.0b013e328361d48e"},{"key":"17","unstructured":"Pyne, C.C., & Apple, S. (2013). Common cardiovascular disorders. In P.G. Morton & D.K. Fontaine (Eds.), Critical care nursing: A holistic approach (10th ed., pp. 374\u2013390). Philadelphia, PA: Wolters Kluwer Health."},{"key":"18","doi-asserted-by":"crossref","unstructured":"Ranasinghe, A.M., Strong, D., Boland, B., & Bosner, R.S. (2011). Acute aortic dissection. BMJ, 343. doi:10.1136\/bmj.d4487","DOI":"10.1136\/bmj.d4487"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Scher, H.I., Fizazi, K., Saad, F., Taplin, M., Sternberg, C.N., Miller, K., . . . de Bono, J.S. (2012). Increased survival with enzalutamide in prostate cancer after chemotherapy. New England Journal of Medicine, 367, 1187\u20131197. doi:10.1056\/NEJMoa1207506","DOI":"10.1056\/NEJMoa1207506"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Sonnek, F.C., & van Muilekom, E. (2013). Metastatic castration-resistant prostate cancer. Part 2: Helping patients make informed choices and managing treatment side effects. European Journal of Oncology Nursing, 17(Suppl. 1), S7\u2013S12.","DOI":"10.1016\/S1462-3889(14)70003-1"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Sternberg, C.N., Petrylak, D.P., Madan, R.A., & Parker, C. (2014). Progress in the treatment of advanced prostate cancer. Retrieved from http:\/\/meetinglibrary.asco\u2028.org\/content\/114000117-144","DOI":"10.14694\/EdBook_AM.2014.34.117"},{"key":"22","unstructured":"Swanson, G.P., Riggs, M.W., & Earle, J.D. (2004). Long-term follow-up of radiotherapy for prostate cancer. International Journal of Radiation Oncology, Biology and Physics, 59, 406\u2013411. doi:10.1016\/j\u2028.ijrobp.2003.10.026"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Wang, E.H., Gross, C.P., Tilburt, J.C., Yu, J.B., Nguyen, P.L., Smaldone, M.C., . . . Kim, S.P. (2015). Shared decision making and use of decision aids for localized prostate cancer. JAMA Internal Medicine, 175, 792\u2013799.","DOI":"10.1001\/jamainternmed.2015.63"},{"key":"24","unstructured":"Williams, S.B., & Choueiri, T.K. (2013). Management of biochemical recurrence after localized treatment for prostate cancer. In A. Klein & J.S. Jones (Eds.), Management of prostate cancer (pp. 347\u2013359). New York, NY: Springer."},{"key":"25","unstructured":"World Cancer Research Fund International. (2014). Prostate cancer statistics. Retrieved from http:\/\/www.wcrf.org\/int\/\u2028cancer-facts-figures\/data-specific-cancers \/prostate-cancer-statistics"}],"container-title":["Oncology Nursing Forum"],"original-title":[],"link":[{"URL":"http:\/\/onf.ons.org\/onf\/43\/4\/acute-aortic-dissection-following-treatment-castration-resistant-prostate-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:52:36Z","timestamp":1763754756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/onf\/43\/4\/acute-aortic-dissection-following-treatment-castration-resistant"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,1]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7,1]]}},"URL":"https:\/\/doi.org\/10.1188\/16.onf.413-416","relation":{},"ISSN":["0190-535X","1538-0688"],"issn-type":[{"value":"0190-535X","type":"print"},{"value":"1538-0688","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,1]]}}}